More about
Ifosfamide
News
June 05, 2022
2 min read
Save
Ifosfamide more likely to extend survival than topotecan-cyclophosphamide in Ewing sarcoma
CHICAGO — In what researchers described as the first randomized controlled trial of chemotherapy in relapsed or refractory Ewing sarcoma, high-dose ifosfamide proved more effective in extending survival than topotecan and cyclophosphamide.